参考文献/References:
[1]鲁之中,李军民,胡云芝,等.食管癌患者miR-182表达水平及其对预后的影响[J].中国现代医学杂志,2017,27(24):39-43.
[2]秦福双.MRI对食管癌T分期诊断及手术切除中的评估价值分析[J].中国CT和MRI杂志,2018,16(1):94-97.
[3]周凯,王伟,相加庆.新辅助化放疗联合手术治疗局部晚期食管癌30例[J].中国临床研究,2018,31(10):85-88.
[4]王绿化,傅小龙,陈明,等.放射性肺损伤的诊断及治疗[J].中华放射肿瘤学杂志,2015,24(1):4-9.
[5]郑苗丽,冯勤付.放射性肺损伤的研究进展[J].中华放射肿瘤学杂志,2018,27(7):692-695.
[6]Rabe KF,Hurd S,Anzueto A,et al.Global Initiative forChronic Obstructive Lung Disease.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J].Am J Respir Crit Care Med,2007,176(6):532-555.
[7]闵茜,胡伟国,宋启斌.放射性肺损伤发生机制的研究进展[J].肿瘤学杂志,2016,22(2):88-92.
[8]林佳.胸部肿瘤放疗后致急性放射性肺损伤的相关因素分析[J].现代诊断与治疗,2017,28(17):3242-3244.
[9]Kimura T,Togami T,Takashima H,et al.Radiation pneumonitisin patients with lung and mediastinal tumours:a retrospective study of risk factors focused on pulmonary emphysema[J].Br J Radiol,2012(85):135-141.
[10]Takeda A,Kunieda E,OhasPhi T,et al.Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy[J].Chest,2012,141(4):858-866.
[11]张毅,任秦有,郑瑾,等.放射性肺损伤的研究进展[J].现代肿瘤医学,2015,28(5):712-715.
[12]常晓龙,王明臣,刘雪,等.盐酸氨溴索在放射性肺损伤中的保护作用及对血浆TGF-β1和TNF-α水平的影响[J].广州医药,2015,46(1):8-10.
[13]Takeda A,Ohashi T,Kunieda E,et al.Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereo tactic body radiotherapy(SBRT) in patients with lung tumors[J].Int J Radiat Oncol Biolhys,2010,77(3):685-690.
[14]Yamashita H,Kobayashi-Shibata S,Terahara A,et al.Prescreening based on the presence of CT-scan abnormalities and biomarkers(KL-6 and SP-D)may reduce severe radiation pneumonitis after stereotactic radiotherapy[J].Radiat Oncol,2010(5):32.
[15]杨志勇,陈传喜.非小细胞肺癌患者放射性肺损伤的临床特点分析[J].中国肿瘤临床与康复,2015,21(1):7-8.
[16]王志勇.三维适形放疗并发放射性肺炎的CT影像特点[J].中国医药指南,2017,15(19):159-160.
相似文献/References:
[1]汪 兵,杜 铭.食管癌微创手术与机器人手术的研究[J].医学信息,2018,31(06):34.[doi:10.3969/j.issn.1006-1959.2018.06.012]
WANG Bing,DU Ming.Study on Minimally Invasive Surgery and Robotic Surgery for Esophageal Carcinoma[J].Journal of Medical Information,2018,31(14):34.[doi:10.3969/j.issn.1006-1959.2018.06.012]
[2]许益芬.三维适型放疗与调强放疗在胸中段食管癌根治性放疗中的
剂量学比较[J].医学信息,2018,31(13):73.[doi:10.3969/j.issn.1006-1959.2018.13.021]
XU Yi-fen.Dosimetric Comparison of Three-dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Radical Radiotherapy of Middle Thoracic Esophageal Carcinoma[J].Journal of Medical Information,2018,31(14):73.[doi:10.3969/j.issn.1006-1959.2018.13.021]
[3]茹仙古丽·艾尔西丁,木拉提·哈米提,严传波,等.RF和C4.5决策树在食管癌图像分类中的研究[J].医学信息,2018,31(22):51.[doi:10.3969/j.issn.1006-1959.2018.22.015]
Roxangvl·Arxidin,Murat·Hamit,YAN Chuan-bo,et al.Research on RF and C4.5 Decision Tree in Image Classification of Esophageal Cancer[J].Journal of Medical Information,2018,31(14):51.[doi:10.3969/j.issn.1006-1959.2018.22.015]
[4]刘 慧,付 雅,皈 燕,等.呼吸动度对食管癌靶区影响及呼吸运动管理策略[J].医学信息,2022,35(12):93.[doi:10.3969/j.issn.1006-1959.2022.12.022]
LIU Hui,FU Ya,GUI Yan,et al.Effect of Respiratory Movement on Esophagus Cancer Target Volume and Respiratory Motility Management Stratege[J].Journal of Medical Information,2022,35(14):93.[doi:10.3969/j.issn.1006-1959.2022.12.022]
[5]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Journal of Medical Information,2018,31(14):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[6]赵素素,谭洁琼,党 娟.食管癌术后恢复期补液量与术后恢复的关系[J].医学信息,2021,34(04):88.[doi:10.3969/j.issn.1006-1959.2021.04.023]
ZHAO Su-su,TAN Jie-qiong,DANG Juan.The Relationship Between the Amount of Fluid Supplementation in the Recovery Period and Postoperative Recovery of Esophageal Cancer[J].Journal of Medical Information,2021,34(14):88.[doi:10.3969/j.issn.1006-1959.2021.04.023]
[7]杨玥欣,汪 志,杨 欣,等.食管癌放疗的剂量学和临床疗效研究[J].医学信息,2020,33(04):72.[doi:10.3969/j.issn.1006-1959.2020.04.022]
YANG Yue-xin,WANG Zhi,YANG Xin,et al.Dosimetry and Clinical Efficacy of Radiotherapy for Esophageal Cancer[J].Journal of Medical Information,2020,33(14):72.[doi:10.3969/j.issn.1006-1959.2020.04.022]
[8]文 龙,张 彬.食管癌的治疗现状及趋势分析[J].医学信息,2022,35(18):165.[doi:10.3969/j.issn.1006-1959.2022.18.046]
WEN Long,ZHANG Bin.Treatment Status and Trend Analysis of Esophageal Cancer[J].Journal of Medical Information,2022,35(14):165.[doi:10.3969/j.issn.1006-1959.2022.18.046]
[9]刘安东,刘崇华,王园园.参麦注射液联合放射治疗对中晚期食管癌老年患者的疗效[J].医学信息,2020,33(16):152.[doi:10.3969/j.issn.1006-1959.2020.16.048]
LIU An-dong,LIU Chong-hua,WANG Yuan-yuan.The Effect of Shenmai Injection Combined with Radiotherapy on Elderly Patients with Advanced Esophageal Cancer[J].Journal of Medical Information,2020,33(14):152.[doi:10.3969/j.issn.1006-1959.2020.16.048]
[10]石 慧,赵 琦,杨月月,等.基于中医传承辅助平台总结当代医家治疗食管癌血瘀痰滞证的用药规律[J].医学信息,2022,35(22):49.[doi:10.3969/j.issn.1006-1959.2022.22.008]
SHI Hui,ZHAO Qi,YANG Yue-yue,et al.Summary of Medication Rules of Contemporary Doctors in Treating Esophageal Cancer of Blood Stasis and Phlegm Stagnation Syndrome Based on Traditional Chinese Medicine Inheritance Support System[J].Journal of Medical Information,2022,35(14):49.[doi:10.3969/j.issn.1006-1959.2022.22.008]